- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/06 - Antipsoriatics
Patent holdings for IPC class A61P 17/06
Total number of patents in this class: 3136
10-year publication summary
|
111
|
127
|
118
|
232
|
268
|
256
|
289
|
275
|
238
|
57
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1829 |
44 |
| Takeda Pharmaceutical Company Limited | 2961 |
43 |
| Wisconsin Alumni Research Foundation | 3774 |
38 |
| Janssen Pharmaceutica N.V. | 3839 |
30 |
| Boehringer Ingelheim International GmbH | 4629 |
27 |
| Galderma Research & Development | 440 |
27 |
| Janssen Biotech, Inc. | 1347 |
26 |
| Allergan, Inc. | 2600 |
25 |
| Novartis AG | 11238 |
23 |
| Pfizer Inc. | 3322 |
21 |
| Eli Lilly and Company | 3645 |
21 |
| Osaka University | 3143 |
21 |
| Bristol-myers Squibb Company | 5080 |
19 |
| Incyte Corporation | 918 |
19 |
| F. Hoffmann-La Roche AG | 7958 |
18 |
| Genentech, Inc. | 3742 |
18 |
| Merck Patent GmbH | 5909 |
18 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
18 |
| Pierre Fabre Dermo-Cosmetique | 380 |
18 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
17 |
| Other owners | 2645 |